Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11503-11509

  Wang, Long ^a   Lv, Yisong ^a   Yao, Huixiang ^a   Yin, Li ^a   Shang, Jianhui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Curcumin; Mitochondria damage; Non alcoholic fatty hepatitis

Indexed keywords

ANTIOXIDANT; CURCUMIN; REACTIVE OXYGEN METABOLITE;

ANIMAL; APOPTOSIS; DISEASE MODEL; DRUG EFFECTS; MALE; METABOLISM; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; PATHOLOGY; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CURCUMIN; DISEASE MODELS, ANIMAL; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 85012942149     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006; 49: 450-65.
2. Singal AK, Jampana SC, Weinman SA. Antioxi-dants as therapeutic agents for liver disease. Liver Int 2011; 31: 1432-48.
3. Poljsak B, Šuput D, Milisav I. Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants. Oxid Med Cell Longev 2013; 2013: 956792.
4. Escribá PV, González-Ros JM, Goñi FM, Kinnunen PK, Vigh L, Sánchez-Magraner L, Fernández AM, Busquets X, Horváth I, Barceló-Coblijn G. Membranes: a meeting point for lipids, proteins and therapies. J Cell Mol Med 2008; 12: 829-875.
5. Ayala A, Muñoz MF, Argüelles S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxid Med Cell Longev 2014; 2014: 360438.
6. Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568-74.
7. Pessayre D, Mansouri A, Fromenty B. Nonal-coholic steatosis and steatohepatitis. V. Mito-chondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002; 282: G193-199.
8. Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 14205-18.
9. Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti F, Rimessi A, Duszynski J, Wieckowski MR, Pinton P. Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging. J Signal Transduct 2012; 2012: 329635.
10. Serviddio G, Bellanti F, Vendemiale G, Alto-Mare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011; 5: 233-44.
11. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007.
12. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75.
13. Barzegar A, Moosavi-Movahedi AA. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 2011; 6: e26012.
14. Singh R, Sharma P. Hepato protective Effect of Curcumin on Lindane-induced Oxidative Stress in Male Wistar Rats. Toxicol Int 2011; 18: 124-9.
15. Li B, Wang L, Lu Q, Da W. Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect? Ir J Med Sci 2014; [Epub ahead of print].
16. Brunt EM, Janney CG, Di Bisceglie AM, Neus-Chwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroen-terol 1999; 94: 2467-74.
17. Sun MG, Williams J, Munoz-Pinedo C, Perkins GA, Brown JM, Ellisman MH, Green DR, Frey TG. Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis. Nat Cell Biol 2007; 9: 1057-65.
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8.
19. Spies-Martin D, Sommerburg O, Langhans CD, Leichsenring M. Measurement of 4-hydroxynonenal in small volume blood plasma samples: modification of a gas chromatographic-mass spectrometric method for clinical settings. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 774: 231-9.
20. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005; 42: 928-40.
21. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28.
22. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria insteatohepatitis. Sem Liver Dis 2001; 21: 57-69.
23. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
24. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313: 2263-73.